Abstract:Background: Lung adenocarcinoma (LUAD) is one of the most important subtypes of lung cancer and has a high morbidity and mortality. Inflammatory CXC chemokines in tumor microenvironment can stimulate tumor growth, invasion, and metastasis, affecting the prognosis of patients. However, the differential expression profiles, prognostic values, and specific mechanisms of the CXC chemokine family in LUAD have not been clarified. Methods: Transcriptome expression profile data were extracted from TIMER and TCGA. GEPIA was used to compare the relationship between CXC chemokines and clinicopathologic parameters. The prognostic analysis was performed using a Kaplan-Meier curve in GEPIA. LinkedOmics and TRRUST were applied to conduct the enrichment analysis of the regulatory networks containing the kinase targets, miRNA targets, and transcriptional factor targets. The characteristics of immune infiltration and immune-related clinical outcomes were evaluated with TIMER algorithms. Single-cell RNA sequencing localization analysis of genes as prognostic biomarkers were performed by PanglaoDB. Results: Nine differentially expressed genes were identified in LUAD compared to normal tissues. Aberrant expression of CXCL2 (P =0.0017), CXCL13 (P= 0.0271), CXCL16 (P= 0.016), and CXCL17 (P= 2.14e-5) was significantly correlated with clinical cancer stage. Furthermore, patients with low gene transcription of CXCL 7 (P = 0.017) and high expression of CXCL 17 (P = 0.00045) had a better prognosis in LUAD. We also found that immune cell infiltration was significantly correlated with LUAD microenvironment mediated by CXC chemokines. Cox proportional hazard model test was conducted and indicated that B cell infiltration could prolong the survival of the LUAD patients. CXCL17 exerted anti-tumors effect through pulmonary alveolar type II cells according to single-cell analysis. Conclusion: Our research identified the aberrant expression profiles and prognostic biomarkers of CXC chemokines in LUAD. This detailed analysis of the regulatory factor networks for CXC chemokine gene expression may provide novel insights for selecting potential immunotherapeutic targets.

Prognostic Value and Therapeutic Significance of CCL Chemokines in Gastric Cancer

C-C motif chemokine 22 predicts postoperative prognosis and adjuvant chemotherapeutic benefits in patients with stage II/III gastric cancer.

Chemokine ligand 14 correlates with immune cell infiltration in the gastric cancer microenvironment in predicting unfavorable prognosis

CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration

CXCL13 Expression is Prognostic and Predictive for Postoperative Adjuvant Chemotherapy Benefit in Patients with Gastric Cancer.

Poor Clinical Outcomes and Immunoevasive Contexture in CXCL13+CD8+ T Cells Enriched Gastric Cancer Patients

Inefficient nodulation of chickpea (Cicer arietinum L.) in the arid and Saharan climates in Tunisia bySinorhizobium meliloti biovarmedicaginis

Expression and prognostic role of CXCL5 in gastric cancer

CXC Chemokine Receptor 1 Predicts Postoperative Prognosis and Chemotherapeutic Benefits for TNM II and III Resectable Gastric Cancer Patients.

Upregulated Expression of C-X-C Chemokine Receptor 4 is an Independent Prognostic Predictor for Patients with Gastric Cancer.

Chemokine (C-X-C Motif) Ligand 1 is Associated with Tumor Progression and Poor Prognosis in Patients with Colorectal Cancer

CCL19: a novel prognostic chemokine modulates the tumor immune microenvironment and outcomes of cancers

Expression of Monocyte Chemotactic Protein-1/Ccl2 in Gastric Cancer and Its Relationship with Tumor Hypoxia

Increased Expression of C-C Motif Ligand 2 Associates with Poor Prognosis in Patients with Gastric Cancer after Gastrectomy

Positive expression of chemokine (C-C Motif) ligand 18 and prognosis in cancer: A meta-analysis.

Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma

Pre-operative Detection of CCL18 in Gastric Cancer Patients and Its Significance

Approval on a knife edge

CCL3 Promotes Proliferation of Colorectal Cancer

Chemokine -driven lymphocyte infiltration in human gastric cancer

The Prognostic Value of CXC-chemokine Receptor 2 (CXCR2) in Gastric Cancer Patients